Search Results - "Ohara, Yuuki"

Refine Results
  1. 1
  2. 2

    Phlebotomy as a preventive measure for crocidolite‐induced mesothelioma in male rats by Ohara, Yuuki, Chew, Shan‐Hwu, Shibata, Takahiro, Okazaki, Yasumasa, Yamashita, Kyoko, Toyokuni, Shinya

    Published in Cancer science (01-02-2018)
    “…Malignant mesothelioma (MM) is a rare but socially important neoplasm due to its association with asbestos exposure. Malignant mesothelioma is difficult to…”
    Get full text
    Journal Article
  3. 3

    Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner by Sato, Kotaro, Shi, Lei, Ito, Fumiya, Ohara, Yuuki, Motooka, Yashiro, Tanaka, Hiromasa, Mizuno, Masaaki, Hori, Masaru, Hirayama, Tasuku, Hibi, Hideharu, Toyokuni, Shinya

    “…Oral cancer accounts for ~2% of all cancers worldwide, and therapeutic intervention is closely associated with quality of life. Here, we evaluated the effects…”
    Get full text
    Journal Article
  4. 4

    SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer by Ohara, Yuuki, Tang, Wei, Liu, Huaitian, Yang, Shouhui, Dorsey, Tiffany H., Cawley, Helen, Moreno, Paloma, Chari, Raj, Guest, Mary R., Azizian, Azadeh, Gaedcke, Jochen, Ghadimi, Michael, Hanna, Nader, Ambs, Stefan, Hussain, S. Perwez

    Published in Cell reports (Cambridge) (26-12-2023)
    “…Pancreatic ductal adenocarcinoma (PDAC) exhibits distinct molecular subtypes: classical/progenitor and basal-like/squamous. Our study aimed to identify genes…”
    Get full text
    Journal Article
  5. 5

    Dual preventive benefits of iron elimination by desferal in asbestos‐induced mesothelial carcinogenesis by Jiang, Li, Chew, Shan‐Hwu, Nakamura, Kosuke, Ohara, Yuuki, Akatsuka, Shinya, Toyokuni, Shinya

    Published in Cancer science (01-07-2016)
    “…Asbestos‐induced mesothelial carcinogenesis is currently a profound social issue due to its extremely long incubation period and high mortality rate…”
    Get full text
    Journal Article
  6. 6

    Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model by Ohara, Yuuki, Chew, Shan Hwu, Misawa, Nobuaki, Wang, Shenqi, Somiya, Daiki, Nakamura, Kae, Kajiyama, Hiroaki, Kikkawa, Fumitaka, Tsuyuki, Yuta, Jiang, Li, Yamashita, Kyoko, Sekido, Yoshitaka, Lipson, Kenneth E, Toyokuni, Shinya

    Published in Oncotarget (06-04-2018)
    “…Malignant mesothelioma is an aggressive neoplasm with no particularly effective treatments. We previously reported that overexpression of connective tissue…”
    Get full text
    Journal Article
  7. 7

    Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification by Yamashita, Kyoko, Kohashi, Kenichi, Yamada, Yuichi, Ishii, Takeaki, Nishida, Yoshihiro, Urakawa, Hiroshi, Ito, Ichiro, Takahashi, Mitsuru, Inoue, Takeshi, Ito, Masafumi, Ohara, Yuuki, Oda, Yoshinao, Toyokuni, Shinya

    Published in Histopathology (01-04-2018)
    “…Aims Ossification is found occasionally in dedifferentiated liposarcoma (DDLPS). The aims of this study were to elucidate whether the formed bone tissue is…”
    Get full text
    Journal Article
  8. 8

    An autopsy case report: Differences in radiological images correlate with histology in Erdheim–Chester disease by Ohara, Yuuki, Kato, Seiichi, Yamashita, Daisuke, Satou, Akira, Shimoyama, Yoshie, Hamaie, Chie, Sato, Motoki, Ban, Nobutaro, Yamamoto, Koji, Yamada, Takehiro, Kawai, Hisashi, Ohshima, Koichi, Nakamura, Shigeo, Toyokuni, Shinya

    Published in Pathology international (01-06-2018)
    “…p16 activation caused by oncogenic mutations may represent oncogene‐induced senescence (OIS), a protective mechanism against oncogenic events. However, OIS can…”
    Get full text
    Journal Article
  9. 9

    Acute fulminant invasive pulmonary aspergillosis in an immunocompetent host: An autopsy case report by Ohara, Yuuki, Ito, Takahiko, Ito, Makoto, Yamashita, Kyoko, Toyokuni, Shinya

    Published in Medical mycology case reports (01-06-2018)
    “…A 62-year-old previously healthy male who was a welder/smoker/drinker was admitted to Kani Tono Hospital for severe hypoxemia (Day 0). Initial physical and…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer by Ohara, Yuuki, Valenzuela, Paloma, Hussain, S Perwez

    Published in Trends in cancer (01-07-2022)
    “…Pancreatic ductal adenocarcinoma (PDAC) is characterized by its highly reactive inflammatory desmoplastic stroma with evidence of an extensive tumor stromal…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer by Moreno, Paloma, Ohara, Yuuki, Craig, Amanda J, Liu, Huaitian, Yang, Shouhui, Dorsey, Tiffany H, Zhang, Lin, Panigrahi, Gatikrushna, Cawley, Helen, Azizian, Azadeh, Gaedcke, Jochen, Ghadimi, Michael, Hanna, Nader, Hussain, S Perwez

    Published in Carcinogenesis (New York) (13-08-2024)
    “…Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the…”
    Get full text
    Journal Article
  16. 16

    MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways by Yang, Shouhui, Tang, Wei, Azizian, Azadeh, Gaedcke, Jochen, Ohara, Yuuki, Cawley, Helen, Hanna, Nader, Ghadimi, Michael, Lal, Trisha, Sen, Subrata, Creighton, Chad J, Gao, Jianjun, Putluri, Nagireddy, Ambs, Stefan, Hussain, Perwez

    Published in Carcinogenesis (New York) (12-08-2024)
    “…Abstract Inflammation and aberrant cellular metabolism are widely recognized as hallmarks of cancer. In pancreatic ductal adenocarcinoma (PDAC), inflammatory…”
    Get full text
    Journal Article
  17. 17
  18. 18

    291 - Preclinical Use of CTGF-Specific Monoclonal Antibody for the Treatment of Malignant Mesothelioma by Ohara, Yuuki, Wang, Shenqi, Jiang, Li, Toyokuni, Shinya

    Published in Free radical biology & medicine (01-11-2016)
    “…Malignant mesothelioma (MM) is a tumor mostly caused by asbestos exposure. There are several theories of carcinogenesis, including oxidative stress theory…”
    Get full text
    Journal Article
  19. 19
  20. 20